Methiomeprazine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H24N2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X2R9QTF0OL, chemically known as 10h-phenothiazine-10-propanamine, n,n, .beta.-trimethyl-2- (methylthio)-, monohydrochloride but generally known as methiomeprazine, which bears US NIH Compound Identifier 26430. European Medicines Agency schedules Methiomeprazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08849MIG. The term METHIOMEPRAZINE is an International Non-Proprietary Name. METHIOMEPRAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methiomeprazine under HS 29343090 and SITC 51578. As of Q4 2014, METHIOMEPRAZINE remains the US FDA Preferred Term for this commodity. Methiomeprazine bears US NLM identifiers UMLS ID C0603501 and NCI Concept Code C83955. SMILES: S1C2C(N(CC(CN(C)C)C)C3C1CCCC3)CC(SC)CC2.